These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22474097)

  • 1. Autophagy: a new therapeutic target in cartilage injury and osteoarthritis.
    Lotz M; Caramés B
    J Am Acad Orthop Surg; 2012 Apr; 20(4):261-2. PubMed ID: 22474097
    [No Abstract]   [Full Text] [Related]  

  • 2. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis.
    Caramés B; Hasegawa A; Taniguchi N; Miyaki S; Blanco FJ; Lotz M
    Ann Rheum Dis; 2012 Apr; 71(4):575-81. PubMed ID: 22084394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy in osteoarthritis.
    Li YS; Zhang FJ; Zeng C; Luo W; Xiao WF; Gao SG; Lei GH
    Joint Bone Spine; 2016 Mar; 83(2):143-8. PubMed ID: 26453105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.
    Zhang Y; Vasheghani F; Li YH; Blati M; Simeone K; Fahmi H; Lussier B; Roughley P; Lagares D; Pelletier JP; Martel-Pelletier J; Kapoor M
    Ann Rheum Dis; 2015 Jul; 74(7):1432-40. PubMed ID: 24651621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes.
    Bachar-Wikstrom E; Wikstrom JD; Ariav Y; Tirosh B; Kaiser N; Cerasi E; Leibowitz G
    Diabetes; 2013 Apr; 62(4):1227-37. PubMed ID: 23274896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Discovery of TOR As the Target of Rapamycin.
    Heitman J
    PLoS Pathog; 2015; 11(11):e1005245. PubMed ID: 26540102
    [No Abstract]   [Full Text] [Related]  

  • 8. Autophagy in atherosclerosis: a potential drug target for plaque stabilization.
    Schrijvers DM; De Meyer GR; Martinet W
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2787-91. PubMed ID: 22096098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin decreases autophagy and leads to cartilage degradation.
    Ribeiro M; López de Figueroa P; Blanco FJ; Mendes AF; Caramés B
    Osteoarthritis Cartilage; 2016 Apr; 24(4):731-9. PubMed ID: 26549531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete induction of autophagy is essential for cardioprotection in sepsis.
    Hsieh CH; Pai PY; Hsueh HW; Yuan SS; Hsieh YC
    Ann Surg; 2011 Jun; 253(6):1190-200. PubMed ID: 21412148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TORing the impact of sirolimus on immune health.
    Gollomp K; Teachey DT
    Blood; 2023 Jan; 141(3):212-214. PubMed ID: 36656615
    [No Abstract]   [Full Text] [Related]  

  • 12. Late conversion to mammalian target of rapamycin inhibitor/proliferation signal inhibitors in kidney transplant patients: clinical experience in the last 5 years.
    Sola E; Lopez V; Gutierrez C; Cabello M; Burgos D; Molina MG; Hernandez D
    Transplant Proc; 2010 Oct; 42(8):2859-60. PubMed ID: 20970551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of autophagy in melanocytes contributes to hypopigmented macules in tuberous sclerosis complex.
    Yang F; Yang L; Wataya-Kaneda M; Hasegawa J; Yoshimori T; Tanemura A; Tsuruta D; Katayama I
    J Dermatol Sci; 2018 Feb; 89(2):155-164. PubMed ID: 29146131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease.
    Santos RX; Correia SC; Cardoso S; Carvalho C; Santos MS; Moreira PI
    J Neurochem; 2011 Jun; 117(6):927-36. PubMed ID: 21447003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of autophagy by mTOR-inhibition in myocardial infarction: When size matters.
    Buss SJ; Riffel JH; Katus HA; Hardt SE
    Autophagy; 2010 Feb; 6(2):304-6. PubMed ID: 20104016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Long Journey of mTOR Inhibitors and the Long Path That Is Still Ahead.
    Tedesco Silva H
    Transplantation; 2018 Feb; 102(2S Suppl 1):S1-S2. PubMed ID: 29369969
    [No Abstract]   [Full Text] [Related]  

  • 17. Everolimus: a new mammalian target of rapamycin inhibitor for the treatment of advanced renal cell carcinoma.
    Grgic T; Mis L; Hammond JM
    Ann Pharmacother; 2011 Jan; 45(1):78-83. PubMed ID: 21177421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN.
    Xu X; Roe ND; Weiser-Evans MC; Ren J
    Hypertension; 2014 Apr; 63(4):729-39. PubMed ID: 24446058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin and tuberous sclerosis complex.
    Wataya-Kaneda M
    J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin.
    Mitani A; Ito K; Vuppusetty C; Barnes PJ; Mercado N
    Am J Respir Crit Care Med; 2016 Jan; 193(2):143-53. PubMed ID: 26426522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.